9052 related articles for article (PubMed ID: 1597566)
1. Prognostic significance of proliferation and motility in primary malignant melanoma of the skin.
Smolle J; Hofmann-Wellenhof R; Kerl H
J Cutan Pathol; 1992 Apr; 19(2):110-5. PubMed ID: 1597566
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell proliferation and motility estimates are prognostic factors in malignant melanoma.
Smolle J; Hofmann-Wellenhof R; Kofler R; Soyer HP; Kerl H
Anal Cell Pathol; 1993 Mar; 5(2):113-24. PubMed ID: 8466849
[TBL] [Abstract][Full Text] [Related]
3. Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters.
Soyer HP
J Cutan Pathol; 1991 Aug; 18(4):264-72. PubMed ID: 1719049
[TBL] [Abstract][Full Text] [Related]
4. Relationship of tumor cell motility and morphologic patterns. Part 1. Melanocytic skin tumors.
Smolle J; Smolle-Juettner FM; Stettner H; Kerl H
Am J Dermatopathol; 1992 Jun; 14(3):231-7. PubMed ID: 1510220
[TBL] [Abstract][Full Text] [Related]
5. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
Talve LA; Collan YU; Ekfors TO
J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
[TBL] [Abstract][Full Text] [Related]
6. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
Morton DL; Davtyan DG; Wanek LA; Foshag LJ; Cochran AJ
Cancer; 1993 Jun; 71(11):3737-43. PubMed ID: 8490924
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
[TBL] [Abstract][Full Text] [Related]
9. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.
Hale CS; Qian M; Ma MW; Scanlon P; Berman RS; Shapiro RL; Pavlick AC; Shao Y; Polsky D; Osman I; Darvishian F
Am J Surg Pathol; 2013 Jun; 37(6):882-9. PubMed ID: 23629443
[TBL] [Abstract][Full Text] [Related]
10. Computer simulation analysis of morphological patterns in human melanocytic skin tumours.
Smolle J; Soyer HP; Smolle-Juettner FM; Stettner H; Kerl H
Pathol Res Pract; 1991 Dec; 187(8):986-92. PubMed ID: 1792195
[TBL] [Abstract][Full Text] [Related]
11. Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation.
Friedman RJ; Rigel DS; Kopf AW; Grin CM; Heilman E; Bart RS; Kamino H; Harris MN; Roses DF; Postel AH
Dermatol Clin; 1991 Oct; 9(4):643-8. PubMed ID: 1934639
[TBL] [Abstract][Full Text] [Related]
12. Proliferation rates in human malignant melanoma: relationship to clinicopathological features and outcome.
Laing JH; Wilson GD; Martindale CA
Melanoma Res; 2003 Jun; 13(3):271-7. PubMed ID: 12777982
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous malignant melanoma.
Maize JC
J Am Acad Dermatol; 1983 Jun; 8(6):857-63. PubMed ID: 6345610
[TBL] [Abstract][Full Text] [Related]
14. Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma.
Bron LP; Scolyer RA; Thompson JF; Hersey P
Pathology; 2004 Dec; 36(6):561-5. PubMed ID: 15841691
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between tumor cell proliferation and prognosis of primary cutaneous malignant melanoma in 127 patients].
Wang Y; Xue WC; Si L; Cui CL; Lu AP; Cao DF; Guo J; Li ZW
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):178-81. PubMed ID: 23769437
[TBL] [Abstract][Full Text] [Related]
16. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
17. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
Karbowniczek M; Chosia M; Domagała W
Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas.
Cruz J; Reis-Filho JS; Silva P; Lopes JM
Oncology; 2003; 65(1):72-82. PubMed ID: 12837985
[TBL] [Abstract][Full Text] [Related]
19. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
